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Crystal structure, biochemical and cellular activities
demonstrate separate functions of MTH1 and
MTH2
Megan Carter1,*, Ann-Sofie Jemth2,*, Anna Hagenkort2,*, Brent D.G. Page2,*, Robert Gustafsson1, Julia J. Griese1,
Helge Gad2, Nicholas C.K. Valerie2, Matthieu Desroses2, Johan Bostro¨m2, Ulrika Warpman Berglund2,
Thomas Helleday2 & Pål Stenmark1
Deregulated redox metabolism in cancer leads to oxidative damage to cellular components
including deoxyribonucleoside triphosphates (dNTPs). Targeting dNTP pool sanitizing
enzymes, such as MTH1, is a highly promising anticancer strategy. The MTH2 protein,
known as NUDT15, is described as the second human homologue of bacterial MutT with
8-oxo-dGTPase activity. We present the first NUDT15 crystal structure and demonstrate that
NUDT15 prefers other nucleotide substrates over 8-oxo-dGTP. Key structural features are
identified that explain different substrate preferences for NUDT15 and MTH1. We find that
depletion of NUDT15 has no effect on incorporation of 8-oxo-dGTP into DNA and does not
impact cancer cell survival in cell lines tested. NUDT17 and NUDT18 were also profiled and
found to have far less activity than MTH1 against oxidized nucleotides. We show that
NUDT15 is not a biologically relevant 8-oxo-dGTPase, and that MTH1 is the most prominent
sanitizer of the cellular dNTP pool known to date.
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D
espite advances in targeted therapies and personalized
medicine, DNA damaging treatments such as radio- and
chemotherapy remain the primary anticancer treatment
modality1. These treatments induce damage indiscriminately and
often result in dose-limiting side effects that reduce patients’
quality of life1–3. Because of the unspecific nature of DNA
damaging agents, advanced metastasized cancers are rarely
cured and cancer remains one of the most common causes
of death.
Altered metabolic and redox activities in cancer cells increase
the production of reactive oxygen species that can cause DNA
damage4,5. While bases in DNA are protected by the double helix
and nucleosome packing, free deoxyribonucleoside triphosphates
(dNTPs) are unprotected and therefore more easily damaged6.
Thus, for cancer cells with deregulated reactive oxygen species,
nucleotide pool sanitizing enzymes are critically important, as
damaged dNTPs can be incorporated into the DNA thus inducing
mutations and DNA damage.
First discovered in Escherichia coli, the NUDIX protein MutT
was identified as a sanitizer of the oxidized dNTP pool7. MutT
selectively hydrolyses 8-oxo-dGTP to 8-oxo-dGMP, thus
preventing 8-oxo-guanine from being incorporated into DNA
and subsequent A:T-C:G transversion mutations7. In this way,
MutT serves as a ‘house-keeping’ enzyme that maintains DNA
integrity by preventing 8-oxo-dG-induced mutations. The
NUDIX hydrolase superfamily is widespread, found in 4250
species in eukaryotes, bacteria and archaea. Members of this
family consist mainly of pyrophosphohydrolases that act upon
nucleoside diphosphatates linked to other moieties, X (NUDIX)8.
The human genome has 24 NUDIX hydrolase genes and at least 5
pseudogenes that display considerable substrate diversity. The
substrate diversity of NUDIX family proteins is to be expected
given that the identifying sequence motif encompasses the
metal binding and catalytic site, whereas substrate recognition
and selectivity are carried out by variable regions within the
superfamily. Multiple functional human homologues of MutT
have been suggested, including NUDT1 (MutT homologue 1,
MTH1; ref. 9), NUDT15 (MutT homologue 2, MTH2; refs 10,11)
and NUDT18 (MutT homologue 3, MTH3; ref. 12). NUDT17 is a
close familial relative of MTH1 whose activity has yet to be
explored12.
The MTH1 protein is the best characterized of the suggested
MutT homologues. We and others have recently demonstrated
that MTH1 is critical for the survival of cancer cells where
oxidative damage to dNTPs is prominent13–15. Interestingly,
MTH1 is not essential in non-transformed cells13,14, and
MTH1 / knockout mice are viable with a similar lifespan as
wild-type mice16. For these reasons, MTH1 inhibition has shown
great potential as a novel strategy to treat cancer—a concept
coined ‘cancer phenotypic lethality’13. Despite the promise of
first-in-class MTH1 inhibitors, there is a concern that NUDT15
or other dNTP sanitizing enzymes may compensate for lost
MTH1 activity. Hence, we sought to investigate other enzymes
that sanitize the dNTP pool and determine whether these
enzymes might be targeted to induce cancer phenotypic
lethality or overcome resistance to MTH1 inhibitors.
NUDT15 is reported to convert 8-oxo-dGTP and 8-oxo-dGDP
to 8-oxo-dGMP10, whereas NUDT18 is known to hydrolyse
8-oxo-dGDP to 8-oxo-dGMP12. The activity of NUDT15 towards
8-oxo-dGTP has led to the assumption that it may contribute to
sanitizing the oxidized dNTP pool. While NUDT15 loss has been
shown to increase mutation frequency 1.5-fold upon exposure
to 8-oxo-dGTP10,11, the in vitro activity of NUDT15 against
8-oxo-dGTP is much lower than the activity of MTH1 towards
8-oxo-dGTP or 2-OH-dATP12,17. Despite rather strong claims
supporting NUDT15 as an 8-oxo-dGTP hydrolase, extensive
profiling of human NUDT15 is noticeably lacking within the
scientific literature.
Here, we solve the first crystal structure of NUDT15 and
elucidate major structural differences compared with MTH1,
especially in the enzymatic pocket. We demonstrate that NUDT15
has considerably lower activity to oxidized guanine species than to
the undamaged nucleotides. Furthermore, knockdown of NUDT15
does not influence the level of 8-oxo-dG incorporation into DNA
or cancer cell survival, suggesting that the enzyme does not sanitize
8-oxo-dGTP in cells. We also test NUDT17 and NUDT18 for their
activity against a panel of oxidized and canonical NUDIX
substrates and show that these enzymes have poor activity against
oxidized dNTPs compared with MTH1. Altogether, we conclude
that MTH1 is the major sanitizer of the oxidized dNTP pool with
little or no overlapping functions of NUDT15, NUDT17 and
NUDT18.
Results
MTH1 is a major sanitizer of 8-oxo-dGTP and 2-OH-dATP.
The MTH1 protein is a well-studied NUDIX protein that
hydrolyses oxidized adenosine and guanosine triphosphates, thus
preventing their incorporation into DNA. Similar to MTH1,
other NUDIX proteins have proposed roles as dNTP pool
sanitizers and may function in concert with MTH1 or may act as
compensatory enzymes if the activity of MTH1 is lost. In the
search for potential anticancer targets that sanitize the oxidized
nucleotide pool, we investigated other MutT homologues with
reported activity towards oxidized nucleotides (NUDT15 and
NUDT18). NUDT17 was also analysed as it is closely related to
the human MutT homologues12. These enzymes were purified
and screened for activity against oxidized and canonical
nucleoside triphosphates and diphosphates (substrate
abbreviations found in Supplementary Table 1) using a
malachite green-based assay (Fig. 1a and Supplementary Fig. 1).
While MTH1 demonstrated strong activity towards 8-oxo-dGTP,
2-OH-ATP and 2-OH-dATP, none of the other proposed dNTP
pool sanitizing enzymes showed appreciable activity with
oxidized nucleotides.
Of these enzymes, NUDT15 showed the second highest activity
against 8-oxo-dGTP (Fig. 1a), but had much stronger activity
towards 20-Deoxyguanosine-50-triphosphate (dGTP) (Fig. 1a–c).
To more thoroughly compare the activity of NUDT15 and
MTH1, kinetic analysis of each enzyme using 8-oxo-dGTP and
dGTP as substrates was conducted. Each protein was incubated
with dGTP (0–400 mM) or 8-oxo-dGTP (0–100 mM) in assay
buffer at pH 7.5, pyrophosphate formation was measured and
initial rates were calculated (Fig. 1b). Kinetic parameters were
determined using the Michaelis–Menten equation and are
displayed in Fig. 1c. While MTH1 prefers 8-oxo-dGTP to dGTP
(kcat/Km¼ 840,200 and 19,100M 1 s 1, respectively), NUDT15
had an opposite selectivity profile (kcat/Km¼ 3,600 and
32,400M 1 s 1 towards 8-oxo-dGTP and dGTP, respectively).
MTH1 is a more efficient catalyst of 8-oxo-dGTP hydrolysis
compared with NUDT15, which is reflected in a considerably
higher kcat value (36-fold higher), and an B44-fold lower Km
value for this substrate. MTH1 displays a slightly higher kcat value
compared with NUDT15 towards dGTP, but NUDT15 has a
lower Km value resulting in a similar catalytic efficiency of dGTP
hydrolysis for the two enzymes. High-performance liquid
chromatography (HPLC) experiments confirmed that NUDT15
had minimal activity against 8-oxo-dGTP, whereas MTH1 and
NUDT15 had nearly equal activity against dGTP (Fig. 1d). Thus,
our data show that NUDT15 has a much lower activity towards 8-
oxo-dGTP than MTH1 and prefers dGTP over 8-oxo-dGTP. This
was not the case for NUDT17 and NUDT18, which show higher
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activity with oxidized nucleotides compared with the correspond-
ing canonical nucleotides (Supplementary Fig. 1b). This activity,
however, is very low. Taken together, these data suggest that while
other NUDIX enzymes show some biochemical activity against
oxidized nucleoside diphosphates and triphosphates, the activity
of these enzymes are very modest in comparison with the activity
of MTH1 towards 8-oxo-dGTP and 2-OH-dATP.
The structure of NUDT15 is similar but distinct from MTH1.
Although NUDT15 is similar in sequence to MTH1, we have
demonstrated that NUDT15 has a remarkably low activity
towards 8-oxo-dGTP. To gain insight into the substrate pre-
ference of NUDT15, we determined the structure of the human
NUDT15 protein (Fig. 2). NUDT15 was crystallized in sitting
drop vapour diffusion experiments at 18 C after 2 days in the
conditions described in the Methods section. Crystals were
analysed using the beamline 14.1 at Bessy, Germany, at 100K.
The structure was solved in a P1 space group at a resolution of
1.8 Å. Structure and refinement statistics can be found in Table 1.
The most striking difference between MTH1 and NUDT15 is
that NUDT15 forms a homodimer (Fig. 2a–c). Analysis of the
NUDT15 dimer interface with PISA (protein interfaces, surfaces
and assemblies, an EBI service)18 demonstrates a solvation-free
energy gain of 16.2 kcalmol 1 and a P value upon formation
of the dimer of 0.186, with an interface area of 1,578.5 Å2.
Size-exclusion chromatography and small-angle X-ray scattering
(SAXS) experiments confirm that the dimeric assembly observed
in the crystal structure is also present in solution (Supplementary
Fig. 2).
The overall structure of the NUDT15 monomer follows a
typical NUDIX fold with an a-helix, b-sheet, a-helix arrange-
ment, where the helices reside on opposing sides of a mixed
b-sheet (Fig. 2a,c). NUDT15 also has multiple small regions of
310-helices. The NUDIX box (GX5EX7REUXEEXGU) is located
in the first a-helix relative to the N terminus and contains
residues responsible for magnesium coordination and substrate
hydrolysis. Four magnesium ions are present in the NUDIX box
region (Fig. 2d and Supplementary Fig. 3). Three out of
four magnesium ions exhibited octahedral coordination: Mg1
coordinates Glu63 and 5 water molecules; Mg2 coordinates
Glu63, Glu67 and 4 water molecules; and Mg3 coordinates Glu67,
the carbonyl oxygen of Glu47 and 4 water molecules. The fourth
magnesium ion, Mg4, has trigonal bipyramidal coordination
(equatorial coordination angles that average 119.6) and
coordinates five water molecules, two of which are bridged with
Mg1 and one is bridged with Mg2. While the presence of four
magnesium ions may not be physiologically relevant, the
structural differences between MTH1 and NUDT15 may have
profound impact on the biological roles of these enzymes.
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Figure 1 | Comparison of NUDIX protein activity with nucleotide substrates. (a) Nucleotide substrate (50 mM) was incubated with 5–500nM NUDIX
protein depending on enzyme. Hydrolysis was monitored by detecting phosphate generated. The depicted data are representative of two independent
experiments showing the same result. Data are presented as v (hydrolysed substrate (mM) per minute) per [enzyme] (mM). (b) Saturation curves and
kinetic parameters of MTH1- and NUDT15-mediated hydrolysis of 8-oxo-dGTP (left) and dGTP (right). NUDT15 (8 nM) or MTH1 (0.25 nM) was incubated
with 8-oxo-dGTP at concentrations ranging from 0 to 100mM in assay buffer, and initial rates were determined in duplicate. Inset highlights NUDT15
activity on a smaller activity scale. NUDT15 (8 nM) and MTH1 (2 nM) were incubated with dGTP in assay buffer ranging from 0 to 400 mM, and initial rates
were determined in duplicate. Data are presented as v (hydrolysed substrate (mM) per second) per [enzyme] (mM), and are representative of data
collected from at least two independent experiments. (c) Kinetic parameters of MTH1 and NUDT15 for dGTP and 8-oxo-dGTP hydrolysis. The Michaelis–
Menten equation was applied to saturation curves using the GraphPad Prism software and kinetic parameters were calculated. Data presented are
average±s.d. from two independent experiments. (d) HPLC chromatograms showing the activity of NUDT15 and MTH1 against 8-oxo-dGTP and dGTP. The
depicted data are representative of three independent experiments and show that MTH1 rapidly hydrolyses 8-oxo-dGTP; however, no significant activity is
observed with NUDT15. Both MTH1 and NUDT15 can hydrolyse dGTP.
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NUDT15 substrate pocket poorly accommodates 8-oxo-dGTP.
While NUDT15 and MTH1 share considerable sequence
homology (Fig. 3a) and are similar in overall structure (Fig. 3b),
there are pronounced differences within the substrate
binding sites that impact substrate recognition. Structural
superimposition of NUDT15 and MTH1 reveals a change in the
orientation of the second a-helix relative to the N terminus
(helix a2) that forms the base of the binding pocket. This
divergence leads to a 5.7 Å shift at the C-terminal end of the
helix19, resulting in a considerably shallower putative binding
pocket for NUDT15 (Fig. 3c). The compositions of the individual
binding pockets are also markedly different. In MTH1, Asp119
and Asp120 make up the base of the binding pocket and form
hydrogen bonds with 8-oxo-dGMP (Fig. 3d). In NUDT15,
Trp136 and Gly137 occupy equivalent positions but are unable
to form the same hydrogen bonding network. Residue Asn33 in
MTH1, which is important for substrate recognition19, is partially
conserved with Gln44 in the NUDT15 structure. However, Gln44
of NUDT15 is not in the same orientation and instead forms
hydrogen bonds with residues of the adjacent b7 and b2 beta
sheets. MTH1 residue Trp117 is involved in pi-stacking
interactions with the substrate and is functionally conserved by
residue Phe135 in NUDT15. The active site differences are
highlighted in Fig. 3d, illustrating that NUDT15 and MTH1 have
distinct binding site features that confer distinct substrate
preferences.
NUDT15 and MTH1 have distinct biological roles. Since
NUDT15 had only limited activity against 8-oxo-dGTP in vitro,
we analysed whether removal of NUDT15 from cells would
increase the 8-oxo-dG content of DNA, induce any DNA damage
markers or impact cancer cell survival. Interestingly, NUDT15
depletion using short interfering RNA (siRNA) had no effect on
the survival of several cancer cell lines (U2OS, NTUB1/p, A375,
H460, MCF7 and SW480; Fig. 4a,b and Supplementary Fig. 4a,b).
This is in strong contrast to MTH1, whose depletion
results in significantly impaired cancer cell survival (Fig. 4a,b).
Furthermore, NUDT15 siRNA depletion did not influence the
survival of MTH1 siRNA-depleted cells, indicating no additive or
synergistic effect of combined knockdown (Fig. 4b). In addition,
no alterations in cell cycle distribution could be detected
after NUDT15 knockdown (Supplementary Fig. 4c,d), and the
NUDT15 expression showed no fluctuations throughout the cell
cycle (Supplementary Fig. 4e). It is established that MTH1 siRNA
depletion results in an increase in DNA damage markers13. Here
we confirm that MTH1 siRNA depletion induces RPA and 53BP1
foci formation, but find no such effect after NUDT15 depletion
(Fig. 4c,d). Altogether, these data suggest that NUDT15 is not
required for prevention of 8-oxo-dGTP incorporation into DNA.
To test this directly, we determined the presence of 8-oxo-dG in
DNA using the modified comet assay after depleting NUDT15 by
siRNA and compared the effect with MTH1 knockdown. In line
with our findings that NUDT15 has a poor 8-oxo-dGTPase
activity, no increase of 8-oxo-dG was observed in DNA following
depletion of NUDT15 by siRNA as was observed when depleting
MTH1 (Fig. 4e,f). Even though siRNA depletion does not lead to
complete removal of the protein, these data further corroborate
that NUDT15 has a limited role in sanitizing the dNTP pool from
8-oxo-dGTP in cells, and that the cellular function is distinct
from MTH1.
Distinct activity profiles of MTH1 and NUDT15. As NUDT15
does not have a significant role in cellular 8-oxo-dGTP
hydrolysis, we tested the activity of NUDT15 against a panel of
potential substrates in vitro. Substrate hydrolysis was assessed
using a malachite green assay (Fig. 5a) and HPLC (Fig. 5b).
Strong correlation was observed between the two analysis
techniques. To our knowledge, there have not been any reports of
post-translational modifications of these enzymes, and we have
not found any indications of such. However, the assays were
90°
x
E63 E67
Mg2Mg1
Mg4 Mg3
Figure 2 | Crystallographic structure of dimeric NUDT15. (a) Top view of
Nudt15 dimer (chain A in cyan and chain B in orange) ribbon representation
with Mg coordination, and the NUDIX box highlighted in magenta.
(b) Surface representation of NUDT15 dimer looking into the putative
binding pocket. (c) Side view of NUDT15 dimer. (d) Four Mg ions in
coordination (green spheres) with multiple waters (red spheres), E63, E67
and carbonyl oxygen of G47 residues in the NUDIX box (magenta).
Table 1 | Data collection and refinement statistics.
PDB ID: 5BON
Data collection
Space group P1
Cell dimensions
a, b, c (Å) 60.8, 71.7, 82.8
a, b, g () 90.1, 90.0, 73.08
Resolution (Å) 47.5–1.8 (1.9-1.8)
Rsym or Rmerge 4.9 (74.7)
I/sI 12.95 (1.4)
Completeness (%) 95.8 (93.9)
Redundancy 1.8 (1.7)
Refinement
Resolution (Å) 47.5–1.8
No. of reflections 118,828
Rwork/Rfree 19.2/22.0
No. of atoms
Protein 10,053
Ligand/ion 31
Water 1,013
B-factors
Protein 36.7
Ligand/ion 33.0
Water 40.8
R.m.s.d.
Bond lengths (Å) 0.004
Bond angles () 0.93
R.m.s.d., root mean squared deviation.
Values in parentheses are for highest-resolution shell. A single crystal was used for data
collection and structure refinement.
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carried out using recombinant, purified enzymes, and differences
from the in vivo activity cannot be ruled out.
Importantly, when comparing the activity of NUDT15 to
MTH1, it is clear that NUDT15 has a distinct selectivity profile
from MTH1 (Fig. 5c). Unlike MTH1, NUDT15 was not active
towards adenosine nucleotides. Of the substrates tested, low
activity was observed towards dCTP, dTTP and 8-oxo-dGTP. The
strongest activity was observed against dGTP, 6-thio-dGTP,
6-thio-GTP and dUTP. Two independent studies have recently
identified NUDT15 as a pharmacogenetic determinant of
thiopurine sensitivity20,21. The particular mutation of NUDT15
leading to sensitivity to thiopurine therapy (Arg139Cys) is located
in helix a2, which forms the base of the substrate binding pocket
(Fig. 5d). This mutation could lead to the formation of a disulfide
bond with the adjacent cysteine residue (Cys140) that may impact
the structure of the enzyme active site. Such structural perturbation
would likely reduce NUDT15 hydrolysis of 6-thio-dGTP in the
cell, causing increased sensitivity to thiopurine treatment.
Discussion
Since the MTH1 protein is a validated target for anticancer
treatments13,22, it is critically important to explore other
proposed dNTP pool sanitation enzymes and assess their
relevance as possible cancer therapeutic targets. Also, these
enzymes may greatly influence the efficiency of MTH1 inhibitors
in the clinic. Here we profiled enzymes suggested to sanitize the
oxidized dNTP pool. Although our data confirm that NUDT15
and NUDT18 have the ability to hydrolyse 8-oxo-dGTP or
8-oxo-dGDP in biochemical assays, this activity was
extremely weak when compared with MTH1 and is not likely
to have physiological relevance. Of the proposed MutT
homologues, NUDT15 had the second highest activity towards
8-oxo-dGTP, but displayed much higher activity towards
canonical dGTP. In fact, NUDT15 displays a nearly 10-fold
preference for dGTP rather than 8-oxo-dGTP as a substrate
(kcat/Km¼ 32,400M 1 s 1 for dGTP and 3,600M 1 s 1 for
8-oxo-dGTP). This is in stark contrast to MTH1 where the
kcat/Km is over 40 times greater for 8-oxo-dGTP than for dGTP.
This may be especially relevant in a biological setting where the
amount of 8-oxo-dGTP is expected to be only a small fraction of
the total dGTP pool. The kinetic values obtained in our
experiments are in agreement with those previously published17,19
for MTH1 activity. Our experiments were conducted at the
physiological pH of 7.5 in which we detected a reaction rate of
8-oxo-dGTP hydrolysis by MTH1 (8.6 s 1) in between the
published kcat values at pH 7.2 (2.1 s 1) and pH 8.0 (12.3 s 1)
while the Km value is similar to that previously reported17. At pH 8,
Fujikawa et al., observe a 13.5-fold preference of 8-oxdGTP over
dGTP as substrate for MTH1. This preference for 8-oxo-dGTP
seems to be more pronounced at pH 7.5 based on the results
presented here. No kinetic parameters of human NUDT15 for any
substrate have been reported previously. However, Takagi et al.12
estimate that MTH1 is B40-fold more active with 8-oxo-dGTP
than NUDT15, which is in agreement with our results.
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Figure 3 | Structural comparison and sequence alignment of NUDT15 and MTH1. (a) Sequence alignment of human NUDT15 with human MTH1
(29% overall sequence identity). The secondary structure of NUDT15 is displayed above the sequence alignment and that of MTH1 below the alignment.
Sequence similarity is represented by yellow boxes, strict sequence identity in red boxes, beta sheets (b) as arrows, alpha-helices (a) and 310-helices (Z) as
squiggles. (b) Superimposition of MTH1 (purple) and NUDT15 (chain A, cyan) with the NUDT15 Mg2þ coordination is shown. Major structural deviation is
observed in helix a2 that affects the depth of the putative binding pocket. (c) Comparison of NUDT15 and MTH1 binding pocket depth. Cut view of surface
representation highlights the variation in binding pocket depth of MTH1 (purple) and Nudt15 (cyan). (d) Comparison of NUDT15 and MTH1 binding pocket
composition. MTH1 helix a2 residues W117, P118, D119, D120 and N33 (grey) are involved in 8-oxo-dG (green) binding. NUDT15 helix a2 residues F135,
W136, G137, L138 and Q44 (grey) form the bottom of the putative binding pocket and are unable to make the equivalent hydrogen bonding network
observed in MTH1 binding to 8-oxo-dGMP.
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Furthermore, while MTH1 depletion led to marked reduction
in clonogenic survival and increased levels of 8-oxo-dG in DNA,
siRNA knockdown of NUDT15 had no effect on cell cycle
progression, clonogenic survival, 8-oxo-dG content of DNA or
DNA damage. Altogether, these data call into question the
importance of NUDT15 in 8-oxo-dGTP sanitation and suggest a
non-vital role of NUDT15 in this realm.
The poor activity of NUDT15 towards 8-oxo-dGTP can be
explained by studying the crystal structure. While NUDT15 and
MTH1 share a similar overall fold, a shift in NUDT15 helix a2
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Figure 4 | Effect of NUDT15 knockdown on clonogenic survival, DNA damage responses and 8-oxo-dG levels in DNA. (a) Western blot showing
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immunofluorescence. (d) Quantification of 53BP1- and RPA-positive cells (45 foci per cell) from c; (n¼ 2). (e) Quantification of the tail moment after
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results in distortion of the substrate binding pocket
compared with MTH1. In addition, MTH1 and NUDT15 have
different residues that make up the base of their active sites,
thereby conferring different substrate recognition. MTH1
has no direct contacts with the 8-oxo group of 8-oxo-dGTP;
however, the crystal structure and mutational studies have
demonstrated the importance of Asp119 and Trp117 in 8-oxo-
dGTP recognition19,23. It has been suggested that the 8-oxo
modification results in electronic changes that strengthen the
hydrogen bonding interactions and/or the base-stacking
interactions of 8-oxo-dGTP compared with dGTP19,24.
NUDT15 lacks similar hydrogen bonding capabilities and does
not maintain the same stacking interaction provided by Trp117 of
MTH1, so it does not exhibit the same affinity for the oxidized
nucleotides.
Since it appears that NUDT15 is not primarily involved in
8-oxo-guanine metabolism, we analysed its activity against a
panel of potential NUDIX substrates. We conducted two
independent substrate screens: one monitoring the formation of
pyrophosphate using a malachite green-based assay and the other
monitoring substrate hydrolysis by HPLC. Both assays showed
that NUDT15 had low activity towards dTTP, dCTP and 8-oxo-
dGTP, and higher activity towards dGTP, 6-thio-dGTP and 6-
thio-GTP. While these represent novel NUDT15 substrates, the
activity of NUDT15 against these substrates was quite low in
comparison with MTH1 activity against 8-oxo-dGTP and 2-OH-
dATP. The activity of NUDT15 towards 6-thioguanine species is
especially interesting given that a NUDT15 mutation was recently
identified as a sensitivity factor in thiopurine therapy20,21. While
our data support a role for NUDT15 in thiopurine metabolism,
further investigation into this topic is of great interest, as
thiopurines are used in the treatment of cancer and autoimmune
disease.
In conclusion, we demonstrate that MTH1 is the major, and
perhaps only, NUDIX family member with a cellular role as a
sanitizer of the oxidized dNTP pool. We demonstrate that
NUDT15 is structurally distinct from MTH1, explaining the
different substrate profile of NUDT15. We show that NUDT15
has a nonessential role in the survival of cancer cells but may be a
mediator of thiopurine therapeutic effectiveness.
Methods
Expression and purification of recombinant NUDIX proteins. The bacterial
expression construct pNIC28hNUDT15 was a kind gift from the Structural
Genome Consortium (Stockholm, Sweden). cDNAs encoding NUDT17 and
NUDT18 were optimized for expression in E. coli, purchased from GeneART
(Life Technologies) and subcloned into pET28a(þ ) (Novagen). The constructs
were verified by sequencing. His-tagged MTH1, NUDT15, NUDT17 and NUDT18
were expressed in E. coli BL21 (DE3) T1R pRARE2 cells at 18 C overnight after
induction with 0.5mM isopropyl-b-D-thiogalactoside. Cultures were grown in a
LEX system, harvested and lysed using Immobilized metal ion affinity chromato-
graphy (IMAC) lysis buffer (100mM HEPES (pH 8.0), 500mM NaCl, 10mM
imidazole, 10% glycerol and 0.5mM Tris(2-carboxyethyl)phosphine hydrochloride
(TCEP)), and pulsed sonication was performed. His-tagged proteins were affinity
purified using HisTrap HP (GE Healthcare) followed by gel filtration using HiLoad
16/60 Superdex 75 (GE Healthcare) in gel filtration buffer (20mM HEPES (pH
7.5), 300mM NaCl, 10% glycerol and 0.5mM TCEP). The His-tag was removed by
TEV protease or thrombin digestion and separated using a Ni-NTA column or gel
filtration using HiLoad 16/60 Superdex 75 (GE Healthcare). Purity of protein
preparations was examined on SDS–polyacrylamide gel electrophoresis gel
followed by Coomassie staining and concentration was determined using
NanoDrop. The correct mass of the protein preparations was confirmed using mass
spectrometry analysis.
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Figure 5 | Activity of NUDT15 towards potential NUDIX family substrates. (a) Substrate hydrolysis after 30min incubation at 22 C was monitored by
coupling the reaction to an excess of bovine alkaline phosphatase or E. coli pyrophosphatase and measuring inorganic phosphate using malachite green
reagent. Data are presented as v (hydrolysed substrate (mM) per minute) per [NUDT15] (mM). Depicted data are mean±s.d. of triplicates. Experiment was
performed twice with similar results. (b) Relative activity of NUDT15 by HPLC analysis. Activity of 10 nM NUDT15 protein against a panel of potential
NUDIX substrates was measured by HPLC after 30min incubation at 37 C. Enzymatic activity was stopped by addition of trifluoroacetic acid (5%) and
samples were ran under conditions indicated in Methods section. Per cent hydrolysis was calculated by subtracting the peak area at 30min from the area at
time 0 and dividing this by the area at time 0; (n¼ 2). (c) Substrate hydrolysis after 20min incubation at 22 C with NUDT15 (black bars) or MTH1 (white
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Crystallization and structure determination. Full-length NUDT15
(20mgml 1) was crystallized in the presence of a-chymotrypsin (0.2mgml 1) in
20mM HEPES (pH 7.5), 300mM NaCl, 10% glycerol and 1mM TCEP. Sitting
drop vapour diffusion experiments at 18 C were performed, and NUDT15 was
mixed with reservoir solution (30% PEG3350, 0.1M Tris (pH 8.5) and 0.05 M
MgCl2) in a 1:1 or 1:2 ratio. Diffraction quality crystals appeared after 2 days, were
extracted quickly without additional cryoprotectant and flash frozen in liquid
nitrogen. Data collection was performed at beamline 14.1 at Bessy, Germany, at
100K and wavelength 0.9 Å. Data reduction and processing were carried out using
XDS (X-ray Detector Software)25 and programs from the CCP4 (ref. 26) suite. The
structure was solved by molecular replacement of the template structure file with
PDB ID 4KYX using MolRep27, and Arp/wARP28 was used for building the initial
model, followed by iterative building cycles using the Refine program in Phenix29.
The structure was solved in P1 space group owing to issues arising from the
presence of pseudo-translation symmetry. Relevant statistics can be found in
Table 1. Ramachandran outliers totalled 0.3% of the final structure, however, all of
these were glycine residues. The coordinates and structure factors for the structure
presented in this paper was deposited in the PDB under code 5BON.
SAXS analysis. To prepare samples for SAXS measurements, NUDT15 was
additionally purified via gel filtration on a Superdex 200 column (GE Healthcare),
and concentrated to yield samples in a concentration range from 1.5 to
13.5mgml 1 in 20mM HEPES-Na (pH 7.5), 300mM NaCl, 10% (v/v) glycerol
and 2mM TCEP. The flowthrough of the concentration step was used as buffer
reference for SAXS measurements. Samples were centrifuged immediately before
measurement. SAXS data were collected at beamline I911-SAXS/Max II at an X-ray
wavelength of 0.91Å over an s-range of 0.01–0.5 Å 1. The momentum transfer s is
defined as s¼ 4p siny/l, where 2y is the scattering angle and l is the X-ray
wavelength. Scattering profiles of lysozyme, bovine serum albumin and alcohol
dehydrogenase (Sigma-Aldrich) were measured as reference for molecular mass
determination. The ATSAS package30 was used to process and analyse data. The
radius of gyration (Rg) was derived by the Guinier approximation [I(s)¼ I(0)
exp( s2Rg2/3) for s Rgo1.3]. The molecular masses of the solutes were determined
by extrapolating the scattering intensities to zero angle and using a standard curve
obtained from I(0) values and known molecular masses of the reference proteins.
Independent estimates of the molecular mass were obtained from the hydrated
volume of the particles. Theoretical scattering profiles of atomic resolution models
were calculated and fitted to measured profiles with CRYSOL31. Ab initio models
were reconstructed from the experimental data using the programs DAMMIF32
and GASBOR33, initially without imposing any symmetry or other restrictions on
possible models. Since all models were clearly twofold symmetric, further models
were calculated imposing twofold symmetry. Sixteen envelopes that were
independently reconstructed with DAMMIF were aligned and averaged with
SUPCOMB34 and DAMAVER35. An envelope representation was calculated using
the Situs package36, which was also used to dock the atomic resolution model into
the envelope.
Size-exclusion chromatography. A 10/300 GL S75 column was equilibrated on
A¨kta Prime with 20mM HEPES (pH 7.5), 300mM NaCl, 10% glycerol and 0.5mM
TCEP. Loaded protein samples were diluted to 500 ml each within the same buffer
and 1–2mM TCEP. Three separate samples were run over the column: 0.48mg
MTH1, 0.24mg NUDT15 and a combined sample of 0.24mg MTH1 and 0.24mg
NUDT15.
Enzyme activity assays. Hydrolase activity of MTH1, NUDT15, NUDT17 and
NUDT18 was tested with 50 mM canonical and oxidized nucleotides in assay buffer
(0.1M Tris-acetate (pH 8.0), 40mM NaCl, 10mM MgAc, 1mM dithiothreitol and
0.005% Tween-20) after incubation at 22 C for 30min. Enzyme concentrations
used were as follows: MTH1, 5 nM; NUDT15, 25 nM; NUDT17, 500 nM; and
NUDT18, 25 nM. Hydrolysis was monitored by coupling the reaction to an excess
of E. coli pyrophosphatase (Sigma-Aldrich), 0.2Uml 1, and measuring the
absorbance at 630 nm after addition of malachite green reagent37 and incubation
for 15min with agitation. A phosphate standard curve was used to convert the
absorbance to [Pi] (A630¼ 0.01743 [Pi] (mM)). Specific activity of NUDT15 was
determined towards a panel of nucleotide substrates using 75 nM NUDT15 and
50mM of each respective nucleotide after 30min incubation at 22 C in assay
buffer. For direct comparison, NUDT15- and MTH1-specific activities were
determined in parallel using 75 nM NUDT15 for all nucleotides except dGTP
(where 15 nM was used) and 2 nM MTH1. Enzymes were incubated with 50 mM of
respective nucleotides for 20min using the same conditions as described above.
Hydrolase activity was assayed by coupling the reaction to an excess of bovine
alkaline phosphatase (Sigma-Aldrich), 2.5Uml 1, for 8-oxo-dGDP, inosine
diphosphate (IDP) and adenosine diphosphate ribose (ADPR) or E. coli
pyrophosphatase, 0.2Uml 1, (Sigma-Aldrich; the rest of the tested substrates),
producing inorganic phosphate, followed by addition of the malachite green
reagent and measuring the absorbance at 630 nm. To determine kinetic
parameters, a kinetic analysis of NUDT15 and MTH1 activity using dGTP and 8-
oxo-dGTP as substrates was performed. NUDT15 (8 nM) or MTH1 (2 nM) was
incubated with dGTP in the assay buffer described above ranging from 0 to 400 mM
for 10, 20 and 30min in duplicates. NUDT15 (8 nM) or MTH1 (0.25 nM) was
incubated with 8-oxo-dGTP ranging from 0 to 100 mM 8-oxo-dGTP for 10,
20 and 30min in duplicates. Formed pyrophosphate or inoorganic diphospate
(PPi) was detected using PPi Light inorganic pyrophosphatase assay from Lonza. A
PPi standard curve ranging from 0 to 5 mM PPi was included on each assay plate
and used to calculate produced PPi. Initial rates were calculated using linear
regression and for the determination of kinetic parameters, the Michaelis–Menten
equation was fitted to the initial rate data by nonlinear regression using Prism
(GraphPad, La Jolla, CA). The enzyme-catalysed hydrolysis of nucleotide substrates
was also monitored using an HPLC assay. HPLC conditions were adapted from
Pollak et al.38. Briefly, HPLC eluents were prepared as follows. Buffer A: H2O,
10mM K2HPO4, 2mM tetrabutyl ammonium bromide, pH 7.0; and buffer B: 50%
H2O, 50% HPLC grade acetonitrile, 10mM K2HPO4, 2mM tetrabutyl ammonium
bromide, pH 5.5. Samples were run on a
5-mm C18 column, 4 125mm with a flow rate of 1mlmin 1. Linear gradients
from 0 to 50% B over 10min followed by from 50 to 70% B over 10min were used.
The column was then washed with 100% B for 4min and re-equilibrated to 100% A
for 4min. Absorbance detection at 260 nm was used to quantify the amount of
substrates at the time points indicated. Substrate consumption was measured by
HPLC after 30min incubation at 37 C in assay buffer (0.1M Tris-acetate (pH 8.0),
40mM NaCl, 10mM MgAc, 1mM dithiothreitol and 0.005% Tween-20) with
10 nM NUDT15 protein. Enzymatic activity was quenched by adding 10 ml of 5%
solution of trifluoroacetic acid to 30 ml of the reaction mixture. All samples were
then diluted with HPLC buffer A (40 ml), which facilitated loading onto the HPLC.
Per cent hydrolysis was calculated by subtracting the peak areas at time 30min
from the area at time 0 and then dividing this by the area at time 0.
Cell culture. U2OS, A375, HCT116, HEK293T, HeLa, H460, MCF7 and SW480
cells were maintained in a humidified incubator at 5% CO2 and 37 C. Cell lines
were cultured in the following media supplemented with 10% fetal bovine serum
and penicillin/streptomycin: DMEM: MCF7, HEK293T, HeLa; DMEM glutamax:
SW480, A375; RPMI: and H460; McCoy’s: U2OS, HCT116. The cell lines were
regularly checked for mycoplasma with MycoAlert Mycoplasma Detection Kit
(Lonza). U2OS, HEK293T, HCT116, H460, MCF7 and HeLa were obtained from
American Type Culture Collection, SW480 from Walter Bodmer (Oxford
University) and A375 from Jonas Nilsson (University of Gothenburg and
Sahlgrenska University Hospital). None of the used cell lines were listed on
ICLAC or were known to be cross-contaminated.
siRNA transfection. Cells were seeded to reach 50% confluence at the day
of transfection. After 24 h, 10 nM siRNA was transfected using INTERFERin
(Polyplus Transfection), as described by the manufacturer using a final
concentration of 10 nM siRNA. As negative control, the ALLStars negative control
from Qiagen was used. The following oligonucleotide sense-sequences were used:
MTH1 siRNA no. 1 50-GACGACAGCUACUGGUUUC-30 , MTH1 siRNA no.
3 50-CGACGACAGCUACUGGUUU-30 and for NUDT15 a pooled mix of 50%
50-GGAUGUGACUCAUGAUUCATT-30 and 50% 50-CCUCAGUUGUGAAUU
CUUUTT-30. Target sequences of siRNAs used in Supplementary Fig. 4 are as
follows:
Qiagen 4: 50-CAGCAGTACTCTTCTCACTAA-30
Qiagen 6: 50-CTCAAGAGCCTTTCAAGGGTA-30
Qiagen 7: 50-CUGGUGUGAUAUUGUAAUATT-30
Qiagen 8: 50-CCAUCUAAUAUCUGUAUCATT-30
Ambion 1: 50-GGAUGUGACUCAUGAUUCATT-30
Ambion 2: 50-GAAGGAGAAUUACCAUUAUTT-30
Ambion 3: 50-CCUCAGUUGUGAAUUCUUUTT-30
Western blotting. Briefly, protein lysates in lithium dodecyl sulfate (LDS) loading
buffer and Precision Plus Protein Dual Color Standards were separated on NuPage
4–15% gradient gels with MOPS running buffer (Life Technologies), transferred to
nitrocellulose membranes and blocked with 5% bovine serum albumin (BSA) in
tris-buffered saline and tween. Membranes were incubated with primary antibodies
diluted in 5% BSA/TBS-T with agitation at 4 C overnight followed by incubation
with secondary antibodies diluted in 5% BSA/TBS-T for 1 h at room temperature.
The antibody against actin (dilution factor 1:10,000; ab6276; mouse monoclonal)
was obtained from Abcam. NUDT15 (dilution factor 1:500; SC84533; rabbit),
cyclin B1 (dilution factor 1:1,000; SC594; rabbit) and cyclin E (dilution factor
1:1,000; SC198; rabbit) antibodies were bought from Santa Cruz Biotechnology,
and MTH1 (dilution factor 1:1,000; NB100-109; rabbit polyclonal) from Novus
Biologicals. Secondary antibodies against rabbit and mouse were obtained from LI-
COR Biosciences. Protein bands were visualized with an Odyssey Fc Imager and
analysed with Image Studio Software (LI-COR Biosciences). The uncropped images
of western blots are provided in Supplementary Fig. 5.
Clonogenic survival. Cells were transfected by siRNA as described above, and
after 2 days 500 cells were trypsinized, counted and re-seeded into 10-cm Petri
dishes. After 10 days, colonies were stained with 4% methylene blue in MeOH and
counted positive if cell number exceeded 50 cells.
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Immunofluorescence. Cells were seeded on glass coverslips in 12-well formats
24 h after siRNA transfection. Ninety-six hours after transfection, cells were fixed
with 3% paraformaldehyde in PBS and permeabilized with 0.1% Triton X-100 in
PBS for 15min. Before antibody staining, cells were blocked with 3% BSA in PBS
for 45min. Antibodies used were as follows: RPA (dilution factor 1:500; Cell
Signalling; 2,208; rat) and 53BP1 (dilution factor 1:500; Abcam; ab36823; rabbit
polyclonal). Alexa-conjugated secondary antibodies were diluted 1:500 and
incubated for 2 h. DNA was counterstained with 4,6-diamidino-2-phenylindole.
Quantification was done by manual counting of positive cells in the microscope
(n4400 cells per sample). Images were taken with a Zeiss LSM 780 with a  63 oil
objective. For 5-ethynyl-2 deoxyuridine (EdU) analysis, U2OS cells were seeded
into 96-well plates. After 96 h of transfection, 10 mgml 1 EdU was added for
20min as indicated by the manufacturer’s instructions (Invitrogen). Plates were
fixed and stained as indicated above. Images were acquired using the Operetta
(PerkinElmer) and analysed using the Harmony software.
Modified comet assay. After 5 days of siRNA transfection, U2OS cells were
harvested by trypsinization, washed with 1 PBS and resuspended to 1 106 cells
per ml in 1 PBS. Cell suspension was diluted 1:5 in 1.2% low-melting agarose
(37 C). A volume of 80ml of cell suspension was spread on agarose-coated fully
frosted slides (Thermo Fisher Scientific) with the help of a coverslip. Cells were
lysed overnight at 4 C using a buffer containing 10mM Tris (pH 10), 1.5M NaCl,
0.1 M EDTA, 10% dimethylsulfoxide and 1% Triton X-100. After washing the
slides three times with enzyme buffer (40mM HEPES (pH 8.0), 0.1M KCl, 0.5mM
EDTA and 0.2mgml 1 BSA), DNA was exposed to buffer alone or OGG1
(2.0mgml 1) for 45min at 37 C. Slides were washed in enzyme buffer, followed
by incubation in alkaline electrophoresis buffer (40mM HEPES (pH 8.0), 0.1M
KCl, 0.5mM EDTA and 0.2mgml 1 BSA) for 30min. The gel electrophoresis
condition used was 300mA, 25V for 30min in electrophoresis buffer. After
neutralization (0.4M Tris-HCl, pH 7.5), DNA was stained using SybrGold dye
(Invitrogen) and images were taken with a  10 objective of a Zeiss LSM 780
confocal microscope. Comets were analysed using CometScore software and tail
moment was calculated as per cent DNA in the tail multiplied by the tail length.
Propidium iodine staining. Seventy-two hours after siRNA treatment, cells were
lysed and DNA was stained with a buffer containing 50 mgml 1 propidium iodine,
20mM Tris (pH 8.0), 100mM NaCl, 0.1% NP40 and 20 mgml 1 RNase. After 1 h
incubation in the dark, DNA content was analysed on a Navios flow cytometer
from Beckman Coulter.
Thymidine block. U2OS cells were blocked with a double thymidine block.
Thymidine (2mM; Sigma) was added for 18 h followed by a 9 h period with media.
For the second block, 2mM thymidine was added for 17 h. Cells were released by
washing with PBS and addition of media. Western blot samples were taken at the
indicated time points.
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